BioMarin Pharmaceutical | Le Coût Des Ventes



Cost Of Sales Changement Date
Acadia Pharmaceuticals USD 20.73M 342K 2025-06
Agios Pharmaceuticals USD 1.7M 617K 2025-06
Alnylam Pharmaceuticals USD 142.95M 71.91M 2025-06
Amgen USD 3.01B 406M 2025-06
Bayer EUR 4.36B 1.26B 2025-06
Biogen USD 605M 24.3M 2025-06
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
Incyte USD 78.77M 10.96M 2025-06
Insmed USD 29.34M 8.06M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
Moderna USD 119M 29M 2025-06
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
PTC Therapeutics USD 15.48M 2.62M 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.99B 721M 2025-06
Sarepta Therapeutics USD 153.22M 15.66M 2025-06
Ultragenyx Pharmaceutical USD 23M 5.66M 2025-06
United Therapeutics USD 175.2M 102.3M 2025-06
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06


BioMarin Pharmaceutical Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.